Celebrity Inventors
Penn Jillette of Penn and Teller fame has patented a "Hydro-Therapeutic Stimulator", which uses a hot tub for stimulation.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7649019 | Modified release formulations of a bupropion salt The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a m... | 01/19/2010 |
| 7390833 | Method for treating ADAMTS-5-associated disease The present invention relates to methods of treating ADAMTS-5-associated diseases and particularly osteoarthritis comprising administering an agent capable of modulating ADMATS-5 activity to a subject afflicted with the disease. The agent is preferably a biaryl sulf... | 06/24/2008 |
| 7309755 | Method of producing polycarbonate articles by rotation molding and rotation molded articles made by the method A method for making a polycarbonate article is described wherein the article is made by rotation molding a melt polycarbonate having a weight average molecular weight from 25,000 to about 36,000. The melt polycarbonate is produced by transesterifying a diaryl carbon... | 12/18/2007 |
| 7297817 | Thio-substituted arylmethanesulfinyl derivatives The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein ... | 11/20/2007 |
| 7161022 | Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative A 4-phenyl-4-oxo-2-butenoate derivative is stably supplied in a short period of time, at low cost, in high purity and on an industrial scale by a process for producing the 4-phenyl-4-oxo-2-butenoate derivative, which comprises simultaneously or continuously reacting... | 01/09/2007 |
| 7135497 | Treating neural conditions resulting from spinal cord contusions and other causes β2-agonists, such as clenbuterol and salbutamol can enhance the recovery of locomotive function and/or neuromuscular strength following spinal cord injuries or as a result of degenerative neural conditions such as Mnd. Pharmacological compositions for tr... | 11/14/2006 |
| 7101888 | Oral liquid tolterodine composition A pharmaceutical composition in a form of an orally deliverable liquid comprises water having in solution therein a pharmaceutically acceptable water-soluble salt of a tolterodine related compound at a therapeutically effective concentration in the composition. The ... | 09/05/2006 |
| 7067555 | Sertraline oral concentrate The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present in... | 06/27/2006 |
| 7014864 | Formulations comprising lipid-regulating agents The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one structured lipid as the primary solvent medium for said agent. One or more emulsifiers may be added to the formulation. ... | 03/21/2006 |
| 7005449 | Tolterodine salts The present invention concerns novel pharmaceutically active compounds, pharmaceutical compositions containing the same, the compounds for use as medicaments, and use of the compounds for the manufacture of specific medicaments. The present invention also concerns a... | 02/28/2006 |
| 6984389 | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a non-vaccine treatment modality. In particular, an HSP preparation or an α2M ... | 01/10/2006 |
| 6982097 | Biocidal compositions and methods of using same This invention relates to biocidal compositions and methods of using same. Also provided is a process for the manufacturing of a biocidal composition in the form of a tablet and a method of using the biocidal compositions for the disinfection of water that may conta... | 01/03/2006 |
| 6855341 | Anti-viral compositions and methods of making and using the anti-viral compositions Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating lesionous symptoms of a viral infection involvi... | 02/15/2005 |
| 6838091 | Formulations comprising lipid-regulating agents The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one monoglyceride as the primary solvent medium for said agent. One or more emulsifiers may be added to the formulation. ... | 01/04/2005 |
| 6750229 | Methods for treating skin pigmentation This invention relates to methods and compositions for bringing about changes in skin pigmentation. More particularly, this invention relates to compounds which affect melanogenesis and can be used as depigmenting agents or as agents for darkening skin utilizing the... | 06/15/2004 |
| 6730702 | Therapeutic agents for inflammatory diseases of intestine The present invention provides a novel agent for prophylaxis or treatment of inflammatory bowel diseases for oral administration or intra-intestinal infusion, which comprises as an active ingredient a compound of the formula (I): | 05/04/2004 |
| 6730667 | Iontophoresis disc pain blocker Treatment of pain syndromes utilizes a topical polypharmaceutical preparation of phenoxybenzamine, ketamine, gabapentin, nifedipine, carbamazepine, or combinations of them. Other suitable components are blockers of sympathetic alpha 1, 2 and other receptors, NMDA re... | 05/04/2004 |
| 6610689 | HIV protease inhibitors based on amino acid derivatives A compound selected from the group consisting of a compound of formula I ##STR1## a compound of formula II ##STR2## and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1 | 08/26/2003 |
| 6576664 | Inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis This invention relates to molecules which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). In particular, the compounds are inhibitors of metalloproteinases involved in tissue degradation and inhibitors... | 06/10/2003 |
| 6468554 | Sensorially active substance embedded in plastic Denatonium benzoate (Bitrex™) dissolves in molten flexible polyvinyl chloride, imparting a bitter flavor to the plastic which discourages rats from gnawing on it. Denatonium benzoate can in all likelihood be added to polymers other than polyvinyl chlori... | 10/22/2002 |
| 6372790 | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia A pharmaceutical composition comprising: (i) metformin, optionally in the form one of its pharmaceutically acceptable salts; (ii) a fibrate selected from fenofibrate and bezafibrate; and optionally one or more pharmaceutically acceptable excipients, is su... | 04/16/2002 |
| 6372789 | Bacteriocide compositions for agricultural and horticultural use The novel agricultural and horticultural fungicidal compositions containing as active ingredients a combination of A) 1,1'-iminiodi(octamethylene)diguanidine of the formula ##STR1## (iminoctadine) or an acid addition salt thereof and B) 1,1'-iminiodi(octameth... | 04/16/2002 |
| 6344479 | Method of preventing retinopathy of prematurity in a neonate A method is disclosed of preventing retinopathy of prematurity in a prematurely born neonate susceptible to developing retinopathy of prematurity, which comprises the step of parenterally administering to said prematurely born neonate, a therapeutically e... | 02/05/2002 |
| 6337080 | Insect control mat An insect control mat having a heatable substrate; an insect control active material; and an aversion material in an amount effective to cause a person to avoid retaining the mat in the person's mouth. A method of controlling insects by use of such a mat ... | 01/08/2002 |
| 6248782 | Method of treating viral diseases A therapeutic process for treating disease in mammals caused by retroviruses in which the infected mammal is treated with a ribonucleotide reductase inhibitor such as a polyhydroxy benzoic, mandelic or phenylacetic acid derivative, such as N,3,4-trihydrox... | 06/19/2001 |
| 6221907 | Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same The subject of the invention is the products of formula (I): ##STR1## in which R1, R2, R3, R4, R5 and G are as defined in the description, the dotted lines represent an optional second bond, as well a... | 04/24/2001 |
| 6048849 | Formulations and methods of reducing toxicity of antineoplastic agents This invention provides for pharmaceutical formulations of compounds which are useful as protective agents when administered to patients also receiving antineoplastic drugs. The invention also includes methods of reducing the toxicity of various antineopl... | 04/11/2000 |
| 5998395 | Methods of treating inflammatory dermatosis Inflammatory dermatoses are controlled and cleared by topical application to the affected areas of the skin of a composition containing both a corticosteroid and a retinoid. The combined therapy is more effective than either active ingredient alone and is... | 12/07/1999 |
| 5939459 | Method and composition for treating mammalian disease caused by inflammatory response A method for treating emphysema and other disease states in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediat... | 08/17/1999 |
| 5891856 | Method for protection against genotoxic mutagenesis A method and pharmaceutical for protecting against mutational damage in mammalian cells, irrespective of the nature of the mutagenic event or source of radiational or chemical insult or the like.... | 04/06/1999 |
| 5863941 | Method and composition of a topical treatment of inner ear and labyrinth symptoms Periauricularly administered topical therapy with a carrier system containing local anesthetics is a new and effective treatment of disorders of the inner ear and labyrinth, which has a low incidence of side effects. The use of this type of therapy applie... | 01/26/1999 |
| 5811459 | Ortho substituted aromatic compounds useful as antagonists of the pain enhancing effects of E-type prostaglandins The invention relates to compounds of the formula (I): ##STR1## wherein A, B and D are various ring systems such as phenyl, R1 includes carboxy, R3 is hydrogen or C1-4 alkyl and Z is a linking group such as --(CH(R | 09/22/1998 |
| 5728734 | Pesticide preparation of aqueous suspension type A pesticide preparation of aqueous suspension type which comprises: (a) a 1,1'-iminiodi(octamethylene)diguanidinium tris(alkyl-benzenesulfonate) as an active pesticide ingredient; (b) at least one dispersion stabilizer selected from among alcohols having a deg... | 03/17/1998 |
| 5700833 | Isocarbacyclin derivatives The present invention provides novel isocarbacyclin derivatives useful for search and study of prostacyclin receptor and as a therapeutic drug for central nervous system diseases, which derivatives are expressed by the following formula I!: ##STR1#... | 12/23/1997 |
| 5681838 | Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation The present invention relates to novel substituted amino compounds of the formula I: R1 -(A)a -(B)b -(D)c -(CH2)m -N(R2)-(CH2)n -R3 as defined in the ... | 10/28/1997 |
| 5658954 | Whitefly insecticide A specially formulated environmental insecticide is provided which effectively controls whiteflies and other insects but is safe to humans, farm animals, pets, crops, and fish. The cost-effective non-polluting insecticide can be in the form of a 100% conc... | 08/19/1997 |
| 5637616 | Method for treating diseases mediated by proteases A method for the topical or systemic treatment of disorders mediated by proteases which result in skin or mucosal lesions, and in particular, pemphigus, cicatricial pemphigoid, bullous pemphigoid, lichen planus, and canker sores, is disclosed wherein the ... | 06/10/1997 |
| 5626838 | Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx The present invention provides novel methods for prevention or treatment of primary and recurring squamous cell carcinoma of the oral cavity or oropharynx comprising topical administration, to the oral cavity or oropharynx, of an effective amount of an NS... | 05/06/1997 |
| 5614554 | Reverse transcriptase inhibitors and antiviral agents The present invention provides a reverse transcriptase inhibitor and an antiviral agent comprising at least one member selected from the group consisting of sulfated tyrosines and physiologically acceptable salts thereof as an effective component; and exh... | 03/25/1997 |
| 5614510 | Pharmaceutical composition with improved bioavailability of inositol phosphate The invention relates to an inositol phosphate containing pharmaceutical composition which comprises a nitrogen-containing compound for improvement of the bioavailability of the inositol phosphate in mammals including man at non-parenteral administration.... | 03/25/1997 |
